The Latest Cardiac and Vascular News
BOSTON – Danvers-based Abiomed, Inc. has agreed to pay $3.1 million to resolve allegations that it violated the False Claims Act by purchasing lavish meals for physicians in order to induce them to use Abiomed’s Impella line of heart pumps. The United States contends that Abiomed sought to induce physicians to use its pumps, which cost more than $20,000 each, by buying meals for […]
LOOMINGTON, Ind.–(BUSINESS WIRE)–Today, Cook Medical announced Dan Kaiser as the leader of global research and development (R&D). This dedicated engineering team will connect product development more closely to customer needs and accelerate the process of getting new products to market. “Our R&D team has been reorganized under a global structure […]
TORONTO, March 8, 2018 /PRNewswire/ – Baylis Medical Company is proud to announce that it has been named a 2018 winner of Canada’s Best Managed Companies, one of the country’s leading business award programs honouring excellence in Canadian-owned and managed businesses. Established in 1993, Canada’s Best Managed Companies recognizes those that demonstrate […]
ATLANTA, March 7, 2018 /PRNewswire/ — Fourth Quarter and Recent Business Highlights: Achieved fourth quarter revenues of $52.8 million Achieved double digit revenue growth on a percentage basis in BioGlue®, On-X, and tissue processing Recorded GAAP net loss of ($3.0) million, or ($0.09) per fully diluted common share; Non-GAAP net income of $4.0 million, or $0.11 per fully diluted […]
ALBANY, New York, March 8, 2018 /PRNewswire/ — The global Cardiac Resynchronization Therapy Systems market was valued at approximately US$ 3.1 Bn in 2016 is projected to register cumulative annual growth rate (CAGR) of over 5.3% from 2017 to 2025, according to a new report published by Transparency Market Research (TMR) titled “Cardiac Resynchronization […]
LONDON–(BUSINESS WIRE)– LivaNova PLC (NASDAQ:LIVN) (“LivaNova”) today announced that it has entered into a definitive Stock and Asset Purchase Agreement (“Purchase Agreement”) to divest its Cardiac Rhythm Management business franchise to MicroPort Scientific Corporation (“MicroPort”). LivaNova and MicroPort executed and delivered the Purchase Agreement, pursuant to the terms of a binding Letter of Intent, […]
REDWOOD CITY, Calif., March 02, 2018 (GLOBE NEWSWIRE) — Avinger, Inc. (Nasdaq:AVGR), a leading developer of innovative treatments for peripheral artery disease (PAD), today announced it has regained compliance with Nasdaq listing requirements. In a letter dated March 1, 2018, Nasdaq informed the Company that it has achieved compliance with […]
NEWARK, Del.–(BUSINESS WIRE)–W. L. Gore & Associates today announced that Jason Field, global sales and marketing leader for Gore Medical Products Division, will succeed Terri Kelly in the role of President and CEO effective April 1, 2018. Terri Kelly will continue to serve on Gore’s Board of Directors through July 2018. […]
DUBLIN–(BUSINESS WIRE)–The “Embolic Protection Devices Market by Type (Distal Filter, Distal Occlusion, Proximal Occlusion), Material (Nitinol, Polyurethane), Application (Cardiovascular, Neurovascular, Peripheral), Indication (PCI, SVD, TAVR) – Global Forecast to 2023” report has been added to ResearchAndMarkets.com’s offering. The Global Embolic Protection Devices Market is Projected to Reach USD 604.9 Million By 2023 from USD […]
GALWAY, Ireland–(BUSINESS WIRE)– 4Tech Inc., a leader in the field of transcatheter tricuspid valve repair, announces changes in its leadership team: Tom Fleming will join the company as President and Chief Executive Officer (CEO), effective as of March 2018; and Keith D. Dawkins, M.D., has joined as Chief Medical Officer (CMO), effective immediately. Tom […]
